Tablet Saaz-DS & ATZ 50 Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Azoran Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Zesoris-AZ 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Autorin 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Vaprin Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Azoalfa Tablet 50
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Azanol Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Azin Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Imuzat 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details
Tablet Saaz-DS & Azafly 50mg Tablet
Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)
+ View Interaction Details